Abbott Laboratories (ABT)

Abbott Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	179,530	191,088	191,427	248,869	194,056	153,608
Market Cap Growth	12.07%	-0.18%	-23.08%	28.25%	26.33%	20.92%
Enterprise Value	187,465	198,488	198,030	256,670	205,655	167,607
PE Ratio	32.15	33.39	27.61	35.20	43.17	41.66
PS Ratio	4.45	4.76	4.39	5.78	5.61	4.82
PB Ratio	4.60	4.92	5.19	6.91	5.88	4.91
P/FCF Ratio	36.47	37.77	24.53	28.78	33.90	34.15
P/OCF Ratio	25.13	26.32	19.98	23.63	24.56	25.03
EV/Sales Ratio	4.65	4.95	4.54	5.96	5.94	5.25
EV/EBITDA Ratio	18.02	18.82	16.32	20.90	23.20	21.60
EV/EBIT Ratio	26.17	27.19	22.34	29.35	37.14	35.31
EV/FCF Ratio	38.08	39.23	25.38	29.68	35.93	37.26
Debt / Equity Ratio	0.37	0.38	0.45	0.50	0.57	0.58
Debt / EBITDA Ratio	1.40	1.39	1.38	1.47	2.11	2.34
Debt / FCF Ratio	2.96	2.90	2.15	2.09	3.28	4.03
Quick Ratio	0.95	1.00	1.06	1.28	1.14	0.88
Current Ratio	1.60	1.64	1.63	1.85	1.72	1.44
Asset Turnover	0.55	0.55	0.59	0.58	0.50	0.47
Interest Coverage	11.46	11.46	15.89	16.41	10.14	7.09
Return on Equity (ROE)	14.70%	15.10%	19.10%	20.40%	14.30%	11.70%
Return on Assets (ROA)	7.70%	7.80%	9.40%	9.60%	6.50%	5.40%
Return on Capital (ROIC)	10.20%	10.40%	13.00%	13.42%	9.32%	8.29%
Earnings Yield	3.14%	2.99%	3.62%	2.84%	2.32%	2.40%
FCF Yield	2.74%	2.65%	4.08%	3.47%	2.95%	2.93%
Dividend Yield	2.13%	1.90%	1.70%	1.30%	1.30%	1.50%
Payout Ratio	68.54%	62.20%	47.70%	45.30%	57.10%	61.80%
Buyback Yield / Dilution	0.12%	0.85%	1.40%	-0.17%	-0.28%	-0.62%
Total Shareholder Return	2.25%	2.75%	3.10%	1.13%	1.02%	0.88%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).